Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Pilot Trial of Pregnenolone in Autism [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial of pregnenolone for autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregnenolone (pregnenolone)

Snippet

Sponsor: Stanford University | Conditions: Autism Spectrum Disorder, Autism | Phase 2 | Status: COMPLETED